Increase in the relative abundance of Cd163 positive cells, associated with different neurodegenerative processes, such as Parkinson’s disease [40], AD (this work and [10, 40], ischemic stroke [45] and even tumor-associated macrophages (glioblastoma) [59, 64] have been extensively reported. This evidence concerns the gene CD163 and Alzheimer disease.